<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37500293</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Impaired regulatory function of granzyme B-producing B cells against T cell inflammatory responses in lupus mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000974</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2023-000974</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Recently, a new subtype of granzyme B (GrB)-producing Breg cells has been identified, which was proven to be involved in autoimmune disease. Our recent report demonstrated that GrB-producing Breg cells were correlated with clinical and immunological features of SLE. However, the effect of GrB-producing Breg cells in lupus mice is unclear.</AbstractText><AbstractText Label="METHODS">GrB expression in na&#xef;ve and lupus mouse B cells was analysed using flow cytometry, PCR, ELISA and ELISpot assays. To study the role of GrB-producing B cells in a lupus model, GrB knockout (KO) and wild-type (WT) mice were intraperitoneally injected with monoclonal cells from the mutant mouse strain B6.C-H-2bm12 (bm12) for 2 weeks. In addition, the function of GrB-producing Breg cells in na&#xef;ve and lupus mice was further explored using in vitro B cells-CD4<sup>+</sup>CD25<sup>-</sup> T cell co-culture assays with GrB blockade/KO of B cells.</AbstractText><AbstractText Label="RESULTS">B cells from the spleens of WT C57BL/6 (B6) mice could express and secret GrB (p&lt;0.001). GrB-producing Breg cells from WT mice showed their regulatory functions on CD4<sup>+</sup>CD25<sup>-</sup> T cell. While the frequency of GrB-producing Breg cells was significantly decreased (p=0.001) in lupus mice (p&lt;0.001). Moreover, GrB-producing Breg cells in lupus mice failed to suppress T cell-mediated proinflammatory responses, partially due to the impaired capacity of downregulating the T cell receptor-zeta chain and inducing CD4<sup>+</sup>CD25<sup>-</sup> T cell apoptosis.</AbstractText><AbstractText Label="CONCLUSION">This study further revealed the function and mechanism of GrB-producing Breg cells in regulating T cell homeostasis in lupus mice and highlighted GrB-producing Breg cells as a therapeutic target in SLE.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xue</LastName><ForeName>Jimeng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6546-2220</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Liling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Mingxin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Ranran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ziye</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongchao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Beijing Jishuitan Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Huaqun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Fanlei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China suyin@pkuph.edu.cn fanleihu@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Peking University People's Hospital &amp; Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China suyin@pkuph.edu.cn fanleihu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D053804">Granzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060151" MajorTopicYN="Y">B-Lymphocytes, Regulatory</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">B-lymphocytes</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37500293</ArticleId><ArticleId IdType="pmc">PMC10387741</ArticleId><ArticleId IdType="doi">10.1136/lupus-2023-000974</ArticleId><ArticleId IdType="pii">10/2/e000974</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaul A, Gordon C, Crow MK, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers 2016;2:16039. 10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan L, O&#x2019;Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019;393:2332&#x2013;43. 10.1016/S0140-6736(19)30237-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton CM, Hom JR, Fucile CF, et al. . Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell Immunomics approach. Immunol Rev 2018;284:120&#x2013;31. 10.1111/imr.12660</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12660</ArticleId><ArticleId IdType="pmc">PMC6022284</ArticleId><ArticleId IdType="pubmed">29944759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci 2019;20:6231. 10.3390/ijms20246231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Jacobi AM, Lipsky PE. B cells in Autoimmunity. Arthritis Res Ther 2009;11:247. 10.1186/ar2780</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2780</ArticleId><ArticleId IdType="pmc">PMC2787254</ArticleId><ArticleId IdType="pubmed">19849820</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;rner T, Giesecke C, Lipsky PE. Mechanisms of B cell Autoimmunity in SLE. Arthritis Res Ther 2011;13:243. 10.1186/ar3433</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3433</ArticleId><ArticleId IdType="pmc">PMC3308063</ArticleId><ArticleId IdType="pubmed">22078750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity 2015;42:607&#x2013;12. 10.1016/j.immuni.2015.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.04.005</ArticleId><ArticleId IdType="pubmed">25902480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Rui K, Wang S, et al. . Advances of regulatory B cells in autoimmune diseases. Front Immunol 2021;12:592914. 10.3389/fimmu.2021.592914</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.592914</ArticleId><ArticleId IdType="pmc">PMC8082147</ArticleId><ArticleId IdType="pubmed">33936028</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaud D, Steward CR, Mirlekar B, et al. . Regulatory B cells in cancer. Immunol Rev 2021;299:74&#x2013;92. 10.1111/imr.12939</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12939</ArticleId><ArticleId IdType="pmc">PMC7965344</ArticleId><ArticleId IdType="pubmed">33368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhabbab RY, Nova-Lamperti E, Aravena O, et al. . Regulatory B cells: development, phenotypes, functions, and role in transplantation. Immunol Rev 2019;292:164&#x2013;79. 10.1111/imr.12800</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12800</ArticleId><ArticleId IdType="pubmed">31559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Satitsuksanoa P, Jansen K, et al. . B regulatory cells in allergy. Immunol Rev 2021;299:10&#x2013;30. 10.1111/imr.12937</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12937</ArticleId><ArticleId IdType="pubmed">33345311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta S, Dasgupta S, Bandyopadhyay M. Regulatory B cells in infection, inflammation, and Autoimmunity. Cell Immunol 2020;352:104076. 10.1016/j.cellimm.2020.104076</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2020.104076</ArticleId><ArticleId IdType="pubmed">32143836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen K, Cevhertas L, Ma S, et al. . Regulatory B cells, A to Z. Allergy 2021;76:2699&#x2013;715. 10.1111/all.14763</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14763</ArticleId><ArticleId IdType="pubmed">33544905</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n D, Mansilla MA, Ferrier A, et al. . Immunosuppressive mechanisms of regulatory B cells. Front Immunol 2021;12:611795. 10.3389/fimmu.2021.611795</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.611795</ArticleId><ArticleId IdType="pmc">PMC8118522</ArticleId><ArticleId IdType="pubmed">33995344</ArticleId></ArticleIdList></Reference><Reference><Citation>Blair PA, Nore&#xf1;a LY, Flores-Borja F, et al. . Cd19(+)Cd24(Hi)Cd38(Hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010;32:129&#x2013;40. 10.1016/j.immuni.2009.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.11.009</ArticleId><ArticleId IdType="pubmed">20079667</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinemann K, Wilde B, Hoerning A, et al. . Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients. Scand J Rheumatol 2016;45:312&#x2013;6. 10.3109/03009742.2015.1126346</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2015.1126346</ArticleId><ArticleId IdType="pubmed">26948375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltenmeier C, Gawanbacht A, Beyer T, et al. . Cd4+ T cell-derived IL-21 and deprivation of Cd40 signaling favor the in vivo development of Granzyme B-expressing regulatory B cells in HIV patients. J Immunol 2015;194:3768&#x2013;77. 10.4049/jimmunol.1402568</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1402568</ArticleId><ArticleId IdType="pubmed">25780036</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahrsd&#xf6;rfer B, Blackwell SE, Wooldridge JE, et al. . B-chronic lymphocytic leukemia cells and other B cells can produce Granzyme B and gain cytotoxic potential after Interleukin-21-based activation. Blood 2006;108:2712&#x2013;9. 10.1182/blood-2006-03-014001</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2006-03-014001</ArticleId><ArticleId IdType="pmc">PMC1895576</ArticleId><ArticleId IdType="pubmed">16809616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai M, Xu L, Zhu H, et al. . Impaired Granzyme B-producing regulatory B cells in systemic lupus erythematosus. Mol Immunol 2021;140:217&#x2013;24. 10.1016/j.molimm.2021.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.09.012</ArticleId><ArticleId IdType="pubmed">34749262</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu X, Liu H, et al. . Impairment of Granzyme B-producing regulatory B cells correlates with exacerbated rheumatoid arthritis. Front Immunol 2017;8:768. 10.3389/fimmu.2017.00768</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00768</ArticleId><ArticleId IdType="pmc">PMC5491972</ArticleId><ArticleId IdType="pubmed">28713386</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Zeng Y, Dolff S, et al. . Granzyme B producing B-cells in renal transplant patients. Clin Immunol 2017;184:48&#x2013;53. 10.1016/j.clim.2017.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.04.016</ArticleId><ArticleId IdType="pubmed">28461110</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W-L, Wang R-L, Liu Z, et al. . Granzyme B-producing B cells function as a feedback loop for T helper cells in liver transplant recipients with acute rejection. Inflammation 2021;44:2270&#x2013;8. 10.1007/s10753-021-01498-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01498-9</ArticleId><ArticleId IdType="pubmed">34120305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner S, Dahlke K, Sontheimer K, et al. . Interleukin 21-induced Granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res 2013;73:2468&#x2013;79. 10.1158/0008-5472.CAN-12-3450</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-3450</ArticleId><ArticleId IdType="pubmed">23384943</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabpour M, Rasolmali R, Talei A-R, et al. . Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes. Mol Immunol 2019;114:172&#x2013;8. 10.1016/j.molimm.2019.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2019.07.019</ArticleId><ArticleId IdType="pubmed">31357083</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord SJ, Rajotte RV, Korbutt GS, et al. . Granzyme B: a natural born killer. Immunol Rev 2003;193:31&#x2013;8. 10.1034/j.1600-065x.2003.00044.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-065x.2003.00044.x</ArticleId><ArticleId IdType="pubmed">12752668</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin WA, Cooper DM, Hiebert PR, et al. . Intracellular versus extracellular Granzyme B in immunity and disease: challenging the dogma. Lab Invest 2009;89:1195&#x2013;220. 10.1038/labinvest.2009.91</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2009.91</ArticleId><ArticleId IdType="pmc">PMC7102238</ArticleId><ArticleId IdType="pubmed">19770840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagn M, Jahrsd&#xf6;rfer B. Why do human B cells Secrete Granzyme B? insights into a novel B-cell differentiation pathway. Oncoimmunology 2012;1:1368&#x2013;75. 10.4161/onci.22354</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/onci.22354</ArticleId><ArticleId IdType="pmc">PMC3518509</ArticleId><ArticleId IdType="pubmed">23243600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieckowski E, Wang G-Q, Gastman BR, et al. . Granzyme B-mediated degradation of T-cell receptor Zeta chain. Cancer Res 2002;62:4884&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12208735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gondek DC, Lu L-F, Quezada SA, et al. . Cutting edge: contact-mediated suppression by Cd4+Cd25+ regulatory cells involves a Granzyme B-dependent, Perforin-independent mechanism. J Immunol 2005;174:1783&#x2013;6. 10.4049/jimmunol.174.4.1783</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.4.1783</ArticleId><ArticleId IdType="pubmed">15699103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahrsd&#xf6;rfer B, Vollmer A, Blackwell SE, et al. . Granzyme B produced by human Plasmacytoid Dendritic cells suppresses T-cell expansion. Blood 2010;115:1156&#x2013;65. 10.1182/blood-2009-07-235382</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-07-235382</ArticleId><ArticleId IdType="pmc">PMC2920226</ArticleId><ArticleId IdType="pubmed">19965634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagn M, Schwesinger E, Ebel V, et al. . Human B cells Secrete Granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol 2009;183:1838&#x2013;45. 10.4049/jimmunol.0901066</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901066</ArticleId><ArticleId IdType="pubmed">19592644</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesneau M, Michel L, Dugast E, et al. . Tolerant kidney transplant patients produce B cells with regulatory properties. J Am Soc Nephrol 2015;26:2588&#x2013;98. 10.1681/ASN.2014040404</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014040404</ArticleId><ArticleId IdType="pmc">PMC4587683</ArticleId><ArticleId IdType="pubmed">25644114</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Berre L, Chesneau M, Danger R, et al. . Connection of Bank1, tolerance, regulatory B cells, and apoptosis: perspectives of a Reductionist investigation. Front Immunol 2021;12:589786. 10.3389/fimmu.2021.589786</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.589786</ArticleId><ArticleId IdType="pmc">PMC8015775</ArticleId><ArticleId IdType="pubmed">33815360</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J-Q, Wang J, Li X-L, et al. . A combination of the percentages of IFN-Gamma(+)Cd4(+)T cells and Granzyme B(+)Cd19(+)B cells is associated with acute hepatic rejection: a case control study. J Transl Med 2021;19. 10.1186/s12967-021-02855-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02855-w</ArticleId><ArticleId IdType="pmc">PMC8088570</ArticleId><ArticleId IdType="pubmed">33933100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabani M, Wilde B, H&#xfc;bbers K, et al. . IL-21 dependent Granzyme B production of B-cells is decreased in patients with lupus nephritis. Clin Immunol 2018;188:45&#x2013;51. 10.1016/j.clim.2017.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.12.005</ArticleId><ArticleId IdType="pubmed">29274388</ArticleId></ArticleIdList></Reference><Reference><Citation>Klarquist J, Janssen EM. The Bm12 inducible model of systemic lupus erythematosus (SLE) in C57Bl/6 mice. J Vis Exp 2015:53319. 10.3791/53319</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/53319</ArticleId><ArticleId IdType="pmc">PMC4692688</ArticleId><ArticleId IdType="pubmed">26554458</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner CT, Lim D, Granville DJ. Granzyme B in skin inflammation and disease. Matrix Biol 2019;75&#x2013;76:126&#x2013;40. 10.1016/j.matbio.2017.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2017.12.005</ArticleId><ArticleId IdType="pubmed">29247692</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagn M, Ebel V, Sontheimer K, et al. . Cd5+ B cells from individuals with systemic lupus erythematosus express Granzyme B. Eur J Immunol 2010;40:2060&#x2013;9. 10.1002/eji.200940113</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200940113</ArticleId><ArticleId IdType="pubmed">20394077</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp G, Gyimesi E, Szab&#xf3; K, et al. . Increased IL-21 expression induces Granzyme B in peripheral Cd5(+) B cells as a potential counter-regulatory effect in primary Sj&#xf6;gren's syndrome. Mediators Inflamm 2016;2016:4328372. 10.1155/2016/4328372</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4328372</ArticleId><ArticleId IdType="pmc">PMC4739475</ArticleId><ArticleId IdType="pubmed">26884645</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupi ML, Sarra M, Marafini I, et al. . Plasma cells in the mucosa of patients with inflammatory bowel disease produce Granzyme B and possess cytotoxic activities. J Immunol 2014;192:6083&#x2013;91. 10.4049/jimmunol.1302238</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302238</ArticleId><ArticleId IdType="pubmed">24835396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesneau M, Mai HL, Danger R, et al. . Efficient expansion of human Granzyme B-expressing B cells with potent regulatory properties. J Immunol 2020;205:2391&#x2013;401. 10.4049/jimmunol.2000335</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000335</ArticleId><ArticleId IdType="pubmed">32948686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagn M, Belz GT, Kallies A, et al. . Activated Mouse B cells lack expression of Granzyme B. J Immunol 2012;188:3886&#x2013;92. 10.4049/jimmunol.1103285</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1103285</ArticleId><ArticleId IdType="pubmed">22427643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulati M, Buffa S, Martorana A, et al. . Trafficking phenotype and production of Granzyme B by double negative B cells (Igg(+)Igd(-)Cd27(-)) in the elderly. Exp Gerontol 2014;54:123&#x2013;9. 10.1016/j.exger.2013.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2013.12.011</ArticleId><ArticleId IdType="pubmed">24389059</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Narayanan P, Kang N, et al. . Human plasma cells express Granzyme B. Eur J Immunol 2014;44:275&#x2013;84. 10.1002/eji.201343711</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201343711</ArticleId><ArticleId IdType="pubmed">24114594</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li XL, Cao S, et al. . Decreased Granzyme B(+)Cd19(+)B cells are associated with tumor progression following liver transplantation. Am J Cancer Res 2021;11:4485&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493381</ArticleId><ArticleId IdType="pubmed">34659900</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>